Healthcare-dedicated investment firm OrbiMed Advisors has closed a US$325 million Asian fund, above its US$300 million target and much larger than its first Asian vehicle with US$188 million launched in 2008, according to media reports. The new fund is to focus on investing in drug developers, diagnostics firms and medical device manufacturers in the region. […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.